3 ms·

As far as I know, there isn't any concrete public info on their technology platform. Supposedly it is on the way to address the recent problems. One of the fe

As far as I know, there isn't any concrete public info on their technology platform. Supposedly it is on the way to address the recent problems. One of the few peer-reviewed articles (with Holmes as a co-author) that uses Theranos technology I see indexed on PubMed is ref. [0]. The results aren't mind blowing, and I have issues with their statistics methodology. This article doesn't really go into the technology, and as a reviewer, I would have given them hell for not even including a cursory description. There is also a recent commentary in Clinical Chemistry and Laboratory Medicine that could be of interest, at ref. [1]. [0] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091290/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091290/ [1] http://www.degruyter.com/view/j/cclm.2015.53.issue-7/cclm-2015-0356/cclm-2015-0356.xml http://www.degruyter.com/view/j/cclm.2015.53.issue-7/cclm-20...

Mz 11y ago
Thank you very much. Excerpt from [1]: Are all these accolades enough to guarantee that the company will deliver the promised goods in healthcare? The answer is no. History teaches us that there are numerous examples of seemingly disruptive technologies in healthcare (and especially in diagnostics), developed by high-profile scientists, including Nobel Laureates, which later collapsed, due to their inability to deliver the promised goods. I feel like my sanity is partially restored, and I haven't even finished the first article.
- OopsCriticality 11y ago
  If I may, I'd like to also direct attention to the last paragraph in the "Costs" section. Certainly this perspective is under active debate, but even if Theranos is able to deliver on their promises (and they could), their fundamental hypothesis may be flawed.
  - Mz 11y ago
    Thank you. Very good call. Not at all what I expected it to be, based on the context when you were pointing it out. Very pertinent information and fits with a lot of things I understand to be true.

Mz 11y ago

Thank you very much. Excerpt from [1]: Are all these accolades enough to guarantee that the company will deliver the promised goods in healthcare? The answer is no. History teaches us that there are numerous examples of seemingly disruptive technologies in healthcare (and especially in diagnostics), developed by high-profile scientists, including Nobel Laureates, which later collapsed, due to their inability to deliver the promised goods. I feel like my sanity is partially restored, and I haven't even finished the first article.

OopsCriticality 11y ago
If I may, I'd like to also direct attention to the last paragraph in the "Costs" section. Certainly this perspective is under active debate, but even if Theranos is able to deliver on their promises (and they could), their fundamental hypothesis may be flawed.
- Mz 11y ago
  Thank you. Very good call. Not at all what I expected it to be, based on the context when you were pointing it out. Very pertinent information and fits with a lot of things I understand to be true.